全部名称:注射用戈沙妥珠单抗、Sacituzumab Govitecan for Injection、赛妥珠单抗、拓達維 二、适应症: 1、乳腺癌: (1)局部晚期或转移性三阴性乳腺癌(mTNBC):戈沙妥珠单抗(Sacituzumab govitecan)适用于治疗患有不可切除的局部晚期或转移性三阴性癌症的成年患者,这些患者之前接受过两种或多种全身治疗,其中至少一...
药品别名: 注射用戈沙妥珠单抗/赛妥珠单抗/拓达维/拓達維/Sacituzumab Govitecan for Injection/TRODELVY 剂型: 注射剂 规格: 180mg 有效期: 36个月 原研药厂: IMMUNOMEDICS INC(Gilead吉利德旗下) 产地: 意大利 价格: 详询客服 上市版本: 点击查看 ...
Sacituzumab govitecan Pronunciation:SAK-i-TOOZ-ue-mab-GOE-vi-TEE-kan Generic name:sacituzumab govitecan hziy Brand name:Trodelvy Dosage form:injection for intravenous infusion Drug class:Miscellaneous antineoplastics Medically reviewed byCarmen Pope, BPharm. Last updated on Oct 30, 2024....
【Trodelvy(sacituzumab govitecan-hziy)一般描述】 Trodelvy的活性药物成分为sacituzumab govitecan,这是一种新型、首创的抗体药物偶联物(ADC)药物,由靶向TROP-2抗原的人源化IgG1抗体与化疗药物伊立替康(一种拓扑异构酶I抑制剂)的代谢...
Sacituzumab govitecan (sacituzumab govitecan-hziy; Trodelvy™) is a Trop-2-directed antibody conjugated to a topoisomerase I inhibitor (SN-38) that is being developed by Immunomedics for the treatment of solid tumours, including breast cancer. In April 2020, sacituzumab govitecan received acc...
In addition in an analysis of TCGA data for glioma, Trop-2 expression has been shown to be strongly correlated with proliferation rate, microvessel density. histological grade, and time to death10. Sacituzumab Govitecan (SG, IMMU-132, TRODELVY) is an antibody-drug conjugate (ADC) which ...
For injection: 180 mg off-white to yellowish lyophilized powder in a single-dose vial. Storage And Handling TRODELVY (sacituzumab govitecan-hziy) for injection is a sterile, off-white to yellowish lyophilized powder in a singledose vial. Each TRODELVY vial is individually boxed in a carton: ...
For injection: 180 mg off-white to yellowish lyophilized powder in a single-dose vial. Storage And Handling TRODELVY (sacituzumab govitecan-hziy) for injection is a sterile, off-white to yellowish lyophilized powder in a singledose vial. Each TRODELVY vial is individually boxed in a carton: ...
Sacituzumab Govitecan (SG) is an antibody-drug conjugate that has demonstrated efficacy in patients with TROP-2 expressing epithelial cancers. In a xenograft model of intracranial breast cancer, SG inhibited tumor growth and increased mouse survival. We
Sacituzumab govitecan-hziy powder for injection must be reconstituted and diluted prior to administration. Do not mix or administer simultaneously through the same IV line with any other drug. Reconstitution Remove appropriate number of vials from the refrigerator and allow to reach room temperature....